| New Contrast Agents Hall C |
| 2055. LDRR-001: The First Noncovalent Calix[4]arene-Gd-Albumin MR Contrast Agent, L.H. Bryant, Jr., A.T. Yordanov, J.J. Linnoila, M.W. Brechbiel and J.A. Frank, National Institutes of Health, Bethesda, MD, USA. |
| 2056. ²H NMR Study of the MP 2269-HSA Interaction: A Step Forward to the Dynamics of Non-Covalent Binding, L. Vander Elst, S. Laurent, K. Adzamli and R.N. Muller, University of Mons-Hainaut, Mons, Belgium and Mallinckrodt Inc., St. Louis, MO, USA. |
| 2057. Beneficial Effect of a Slow Water Exchange on the High Field Relaxivity of Dy-DTPA Derivatives, L. Vander Elst, A. Roch, P. Gillis, S. Laurent, F. Botteman, J.W.M. Bulte and R.N. Muller, University of Mons-Hainaut, Mons, Belgium and National Institutes of Health, Bethesda, MD, USA. |
| 2058. Microenvironmental Responsive MRI Contrast Agent Consisting of Polyion Complex for Tumor Sensing, M. Mikawa, N. Miwa, T. Akaike and A. Maruyama, Tokyo Institute of Technology, Yokohama, Japan and Nihon Schering K.K., Osaka, Japan. |
| 2059. Molecular Factors that Determine Curie Spin Relaxation in Dy-Chelates, J.W.M. Bulte, M.T. Greenfield and P. Caravan, National Institutes of Health, Bethesda, MD, USA and EPIX Medical Inc., Cambridge, MA, USA |
| 2060. Blood Clearance of High-Generation Dendrimer-Based Gadolinium Chelates: The Study of a Potentially Saturable Site (Mechanism) in the Rat, L.H. Bryant Jr., E.K. Jordan, J.W.M. Bulte, K. Garmestani and J.A. Frank, National Institutes of Health, Bethesda, MD, USA. |
| 2061. Paramagnetic Relaxation Enhancement in Off-Resonance Rotating Frame: From Gd-DTPA to MION, H. Zhang and A.M. Wyrwicz, ENH Reasearch Institute, Evanston, IL, USA. |
| 2062. Magnetodendrimers as a New Class of Cellular Contrast Agents, J.W.M. Bulte, T. Douglas, E. Strable, B.M. Moskowitz and J.A. Frank, National Institutes of Health, Bethesda, MD, USA; Temple University, Philadelphia, PA, USA and University of Minnesota, Minneapolis, MN, USA. |
| 2063. Pharmacokinetics and Enhancement Patterns of Macromolecular MR Contrast Agents with Various Size of Polyamidoamine Dendrimer Cores, N. Sato, H. Kobayashi, A. Hiraga, T. Saga, K. Togashi, J. Konishi and M.W. Brechbiel, Kyoto University, Kyoto, Japan and National Institutes of Health, Bethesda, MD, USA. |
| 2064. Gadolinium-cDTPAa Conjugated with Melanoma Monoclonal Antibody 9.2.27 as a Melanoma Specific MRI Contrast Agent, D. Shahbazi-Gahrouei, M. Williams, S. Rizvi and B.J. Allen, University of Western Sydney and St. George Hospital, Sydney, Australia. |
| 2065. Liposomes as Carriers of Amphiphilic Gd-Chelates, C. Gløgård, G. Stensrud, R. Hovland, S.L. Fossheim and J. Klaveness, University of Oslo and Nycomed Imaging AS, Oslo, Norway. |
| 2066. Targeted Contrast Agents for Magnetic Resonance Imaging: Possibilities and Limitations, L.O. Johansson, K.E. Kellar, H.K. Ahlström, A. Bjørnerud, B. Douty, D.L. Ladd and D.K. Fujii, Nycomed Amersham Imaging, Oslo, Norway and Uppsala University Hospital, Uppsala, Sweden. |
| 2067. Direct ¹H NMR Observation of a Lanthanide Bound Water in Aqueous Solution, S. Zhang, K. Wu and A.D. Sherry, University of Texas at Dallas, Richardson, TX, USA and University of Texas Southwestern Medical Center, Dallas, TX, USA. |
| 2068. Binding of Gd(III) Complexes to Albumin as Measured by High Field EPR, T.I. Smirnova, A.I. Smirnov, R.L. Belford and R.B. Clarkson, University of Illinois, Urbana, IL, USA. |